{"name":"Sultopride","slug":"sultopride","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Sultopridum","Sultoprida","N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide","Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxy-","N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxy-benzamide","N-((1-ethylpyrrolidin-2-yl)methyl)-5-ethylsulfonyl-2-methoxy-benzamide","(+-)-Sultopride","N05al02","N-(Ethyl-1-pyrrolidinyl-2-methyl)methoxy-2-ethylsulfonyl-5-benzamide","258-641-9"],"brands":["Barnetil","Barnotil","Topral"],"scraped":true,"has_structure":true,"cid":5357,"classes":[],"families":[{"name":"benzylamine","href":"/substituted/benzylamine"}],"physical":[{"label":"Molecular mass","value":"354.50 g/mol","copyable":false},{"label":"Predicted LogP","value":"1.6","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>17</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub>S","copyable":true},{"label":"IUPAC name","value":"N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide","copyable":true},{"label":"SMILES","value":"CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)CC)OC","copyable":true},{"label":"InChI","value":"InChI=1S/C17H26N2O4S/c1-4-19-10-6-7-13(19)12-18-17(20)15-11-14(24(21,22)5-2)8-9-16(15)23-3/h8-9,11,13H,4-7,10,12H2,1-3H3,(H,18,20)","copyable":true},{"label":"InChIKey","value":"UNRHXEPDKXPRTM-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"53583-79-2","copyable":true},{"label":"UNII","value":"AA0G3TW31W","copyable":true},{"label":"PubChem CID","value":"5357","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"3–5 hours","copyable":false},{"label":"Routes of administration","value":"Oral, intramuscular","copyable":false}],"toxicity":[],"dosing":null,"salts":[{"title":"Sultopride hydrochloride","name":"hydrochloride","slug":"sultopride_hydrochloride","drawn":true}],"esters":[],"chirality":"racemic","stereo_type":"enantiomer","optical_activity":"( + / - )","stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N05","description":"Psycholeptics"},{"code":"N05A","description":"Antipsychotics"},{"code":"N05AL","description":"Benzamides"},{"code":"N05AL02","description":"Sultopride"}],"mesh":[{"name":"Antipsychotic Agents","id":"M0021770"},{"name":"Dopamine Antagonists","id":"M0027734"},{"name":"Antidepressive Agents, Second-Generation","id":"M0028000"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"DRD2","mechanisms":["shared target"],"partners":60,"contraindicated":1}],"mechanism":null,"side_effects":null,"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"C1","act":null,"refs":[3]},{"jurisdiction":"Other","status":"Rx-only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Sultopride"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/5357"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q4445779"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB13273"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL277945"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A9356"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=53583-79-2"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0258623"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C11708"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID9023627"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Sultopride"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/AA0G3TW31W"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 5357, Sultopride. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/5357>https://pubchem.ncbi.nlm.nih.gov/compound/5357</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Sultopride. UNII: AA0G3TW31W. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/AA0G3TW31W>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/AA0G3TW31W</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 19:00:24","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 19:00:20","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 19:00:19","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 19:00:21","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 19:00:19","note":"hmdb.ca refused automated access to HMDB0258623"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 19:00:22","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 19:00:18","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 19:00:20","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 19:00:19","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 19:00:19","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 19:00:20","note":null}],"description":"Sultopride is a  substance."}